Skip to main content

Advertisement

SpringerLink
Log in

Diagnosis, staging and treatment of patients with non-small cell lung cancer for the surgeon

  • Review Article
  • Published:
Indian Journal of Surgery Aims and scope Submit manuscript

Abstract

This article covers the risk factors, diagnostic tools, staging methods/modalities and treatment for patients with non-small cell lung cancer (NSCLC). Also presented is the new 7th edition American Joint Cancer Committee (AJCC) TNM classification for staging of NSCLC and a recommended treatment algorithm.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Alberg AJ, Samet JM (2003) Epidemiology of lung cancer. Chest 123(1 Suppl):21S–49S

    Article  PubMed  Google Scholar 

  2. Denissenko MF, Pao A, Tang M, Pfeifer GP (1996) Preferential formation of benzo [a] pyrene adducts at lung cancer mutational hotspots in P53. Science 274(5286): 430–432

    Article  CAS  PubMed  Google Scholar 

  3. Hubbard R, Venn A, Lewis S, Britton J (2000) Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study. Am J Respir Crit Care Med 161(1):5–8

    CAS  PubMed  Google Scholar 

  4. Hakimian R, Fang, Thomas L, Edelman MJ (2007) Lung cancer in HIV infected patients in the era of highly active antiretroviral therapy. J Thorac Oncol 2:268–272

    PubMed  Google Scholar 

  5. Ballaz S, Mulshine JL (2003) The potential contributions of chronic inflammation to lung carcinogenesis. Clin Lung Cancer 5:46–62

    Article  CAS  PubMed  Google Scholar 

  6. Coussens L, Werb Z (2002) Inflammation and cancer. Nature 420:860–867

    Article  CAS  PubMed  Google Scholar 

  7. Engels E (2008) Inflammation in the development of lung cancer: Epidemiological evidence. Expert Rev Anticancer Ther 8:605–615

    Article  CAS  PubMed  Google Scholar 

  8. Singh VK, Chandra S, Kumar S, Pangtey G, Mohan A, Guleria R (2009) A common medical error: Lung cancer misdiagnosed as sputum negative tuberculosis. Asian Pac J Cancer Prev 10:335–338

    PubMed  Google Scholar 

  9. Weiser TS, Hyman K, Litle V, Chin C, Swanson SJ (2008) Electromagnetic navigational bronchoscopy: A surgeon’s perspective. Ann Thor Surg 85:S797–801

    Article  Google Scholar 

  10. Goldstraw P, Crowley J, Chansky K, Giroux DJ, Groome PA, Rami-Porta R, Postmus PE, Rusch V, Sobin L (2007) The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours. Thorac Oncol 2(8):706–714

    Article  Google Scholar 

  11. MacManus MP, Hicks RJ (2003) PET scanning in lung cancer: current status and future directions. Semin Surg Oncol 21:149–155

    Article  Google Scholar 

  12. Cerfolio RJ, Ojha B, MD, Bryant AS, Bass CS, Bartalucci AA, Mountz JM (2003) The role of FDG-PET scan in staging patients with nonsmall cell carcinoma. Ann Thorac Surg 76:861–866

    Article  PubMed  Google Scholar 

  13. Berghmans T, Dusart M, Paesmans M, Hossein-Foucher C, Buvat I, Castaigne C, Scherpereel A, Mascaux C, Moreau M, Roelandts M, Alard S, Meert AP, Patz EF Jr, Lafitte JJ, Sculier JP (2008) Primary tumour standardised uptake value (SUVmax) measur ed on fluorodeoxyglucose positron emission tomography (FDG-PET) is of prognostic value for survival in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis (MA) by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project. J Thorac Oncol 3(1):6–12

    Article  PubMed  Google Scholar 

  14. Cerfolio RJ, Bryant AS (2007) The role of integrated positron emission tomography-computerised tomography in evaluating and staging patients with non-small cell lung cancer. Semin Thorac Cardiovasc Surg 19(3):192–200

    Article  PubMed  Google Scholar 

  15. Bryant AS, Cerfolio RJ (2006) The maximum standardised uptake values on integrated FDG-PET/CT is useful in differentiating benign from malignant pulmonary nodules. Ann Thorac Surg 82(3):1016–1020

    Article  PubMed  Google Scholar 

  16. Bury T, Dowlati A, Paulus P, Corhay JL, Hustinx R, Ghaye B, Radermecker M, Rigo P (1997) Whole-body 18FDG positron emission tomography in the staging of non-small cell lung cancer. Eur Respir J 10(11):2529–2534

    Article  CAS  PubMed  Google Scholar 

  17. van Tinteren H, Hoekstra OS, Smit EF, van den Bergh JH, Schreurs AJ, Stallaert RA, van Velthoven PC, Comans EF, Diepenhorst FW, Verboom P, van Mourik JC, Postmus PE, Boers M, Teule GJ (2002) Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial. Lancet 359(9315):1388–1393

    Article  PubMed  Google Scholar 

  18. Pieterman RM, van Putten JW, Meuselaar JJ, Mooyaart EL, Vaalburg W, Koeter GH, Fidler V, Pruim J, Groen HJ (2000) Preoperative staging of non-small-cell lung cancer with positron-emission tomography. N Engl J Med 343(4): 254–261

    Article  CAS  PubMed  Google Scholar 

  19. De Wever W, Vankan Y, Stroobants S, Verschakelen J (2000) Detection of extrapulmonary lesions with integrated PET/CT in the staging of lung cancer. Eur Respir J 29(5):995–1002

    Article  Google Scholar 

  20. Wynants J, Stroobants S, Dooms C, Vansteenkiste J (2007) Staging of lung cancer. Radiol Clin North Am 45:609–625

    Article  PubMed  Google Scholar 

  21. Song JW, Oh YM, Shim TS, Kim WS, Ryu JS, Choi CM (2009) Efficacy comparison between (18)F-FDG PET/CT and bone scintigraphy in detecting bony metastases of nonsmall-cell lung cancer. Lung Cancer 65:333–338

    Article  PubMed  Google Scholar 

  22. Cerfolio RJ, Bryant AS (2009) Different diffusing capacity of the lung for carbon monoxide as predictors of respiratory morbidity. Ann Thorac Surg 88(2):405–410; discussion 410–411

    Article  PubMed  Google Scholar 

  23. Colice GL, Shafazand S, Griffin JP, et al. (2007) Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest 132:161S

    Article  PubMed  Google Scholar 

  24. Onishi H, Shirato H, Nagata Y, Hiraoka M, Fujino M, Gomi K, Niibe Y, Karasawa K, Hayakawa K, Takai Y, Kimura T, Takeda A, Ouchi A, Hareyama M, Kokubo M, Hara R, Itami J, Yamada K, Araki T (2007) Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multiinstitutional study. J Thorac Oncol 2(7 Suppl 3):S94–100

    Article  PubMed  Google Scholar 

  25. Baumann P, Nyman J, Hoyer M, Wennberg B, Gagliardi G, Lax I, Drugge N, Ekberg L, Friesland S, Johansson KA, Lund JA, Morhed E, Nilsson K, Levin N, Paludan M, Sederholm C, Traberg A, Wittgren L, Lewensohn R (2009) Outcome in a Prospective Phase II Trial of Medically Inoperable Stage I Non-Small-Cell Lung Cancer Patients Treated With Stereotactic Body Radiotherapy. J Clin Oncol 27:3290–3296

    Article  PubMed  Google Scholar 

  26. Lee JM, Jin GY, Goldberg SN, Lee YC, Chung GH, Han YM, Lee SY, Kim CS (2004) Percutaneous radiofrequency ablation for inoperable non-small cell lung cancer and metastases: preliminary report. Radiology 230(1):125–134

    Article  PubMed  Google Scholar 

  27. Cerfolio RJ, Bryant AS, Patel B, Bartolucci AA (2005) Intercostal muscle flap reduces the pain of thoracotomy: a prospective randomised trial. J Thorac Cardiovasc Surg 130(4):987–993

    Article  PubMed  Google Scholar 

  28. Cerfolio RJ, Bryant AS, Maniscalco LM (2008) A nondivided intercostal muscle flap further reduces pain of thoracotomy: a prospective randomised trial. Ann Thorac Surg 85(6):1901–1906; discussion 1906–1907

    Article  PubMed  Google Scholar 

  29. Cerfolio RJ, Price TN, Bryant AS, Sale Bass C, Bartolucci AA (2003) Intracostal sutures decrease the pain of thoracotomy. Ann Thorac Surg 76(2):407–411

    Article  PubMed  Google Scholar 

  30. Cerfolio RJ, Bryant AS (2008) Results of a prospective algorithm to remove chest tubes after pulmonary resection with high output. Ann Thorac Surg 135:269–273

    Google Scholar 

  31. Winton T, Livingston R, Johnson D, Rigas J, Johnston M, Butts C, Cormier Y, Goss G, Inculet R, Vallieres E, Fry W, Bethune D, Ayoub J, Ding K, Seymour L, Graham B, Tsao MS, Gandara D, Kesler K, Demmy T, Shepherd F (2005) Vinorelbine plus Cisplatin vs. Observation in Resected Non-Small-Cell Lung Cancer. N Engl J Med 352(25): 2589–2597

    Article  CAS  PubMed  Google Scholar 

  32. Arriagada R, Bergman B, Dunant A, Le Chevalier T, Pignon JP, Vansteenkiste J (2004) Cisplatin-based adjuvant chemotherapy in patients with completely resected nonsmall-cell lung cancer. N Engl J Med 350(4):351–360

    Article  PubMed  Google Scholar 

  33. Waller D, Gower N, Milroy MD, et al. (2003) Determining the value of cisplatin-based chemotherapy for all patients with non-small cell lung cancer (NSCLC). Preliminary results in the surgical setting (abstract). Proc Am Soc Clin Oncol 22: 639

    Google Scholar 

  34. Scagliotti GV, Fossati R, Torri V, Crino L, Giaccone G, Silvano G, Martelli M, Clerici M, Cognetti F, Tonato M (2003) Randomised study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell Lung cancer. J Natl Cancer Inst 95(19):1453–1461

    CAS  PubMed  Google Scholar 

  35. Douillard JY, Rosell R, De Lena M, Carpagnano F, Ramlau R, Gonzales-Larriba JL, Grodzki T, Pereira JR, Le Groumellec A, Lorusso V, Clary C, Torres AJ, Dahabreh J, Souquet PJ, Astudillo J, Fournel P, Artal-Cortes A, Jassem J, Koubkova L, His P, Riggi M, Hurteloup P (2006) Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): A randomised controlled trial. Lancet Oncol (9):719–727

    Article  Google Scholar 

  36. Pignon JP, Tribodet H, Scagliotti GV, Douillard JY, Shepherd FA, Stephens RJ, Dunant A, Torri V, Rosell R, Seymour L, Spiro SG, Rolland E, Fossati R, Aubert D, Ding K, Waller D, Le Chevalier T (2008) Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group. J Clin Oncol 26(21):3552–3559

    Article  PubMed  Google Scholar 

  37. Sugimura H, Nichols FC, Yang P, Allen MS, Cassivi SD, Deschamps C, Williams BA, Pairolero PC (2007) Survival after recurrent nonsmall-cell lung cancer after complete pulmonary resection. Ann Thorac Surg. 83(2):409–417, discussion 417–418

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Cardiothoracic Surgery, University of Alabama at Birmingham, 703 19th St S, ZRB 739, Birmingham, AL, 35294, USA

    Ayesha S. Bryant

  2. Thoracic Surgery, Division of Cardiothoracic Surgery, University of Alabama at Birmingham, 703 19th St S, ZRB 739, Birmingham, AL, 35294, USA

    Robert J. Cerfolio

Authors
  1. Ayesha S. Bryant
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert J. Cerfolio
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ayesha S. Bryant.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bryant, A.S., Cerfolio, R.J. Diagnosis, staging and treatment of patients with non-small cell lung cancer for the surgeon. Indian J Surg 71, 310–316 (2009). https://doi.org/10.1007/s12262-009-0086-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12262-009-0086-4

Keywords

Search

Navigation